A Trial of SHR-1905 in Subjects With Severe Uncontrolled Asthma
Clinical trial NCT05593250 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05593250
- Sponsor
- Shanghai Hengrui Pharmaceutical Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-17
- Primary completion
- 2026-12-30
- Enrollment
- 260
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.